Logo

Packard BioScience Buys Canadian Firm BioSignal

Dec 18, 1998
Premium

MERIDEN, Conn.--Packard BioScience here said it has acquired BioSignal, a Montreal-based biotechnology research firm. Packard paid approximately $8.5 million for the interest in the company that it did not already own. Packard said it plans to unite BioSignal's gene cloning expertise with the advanced biochip technology that Packard, Motorola, and Argonne National Laboratory recently announced they will develop jointly. Packard said it will be able to incorporate validated drug targets into high-throughput screening platforms for pharmaceutical and biotechnology research.

Filed under

Informatics
Breaking News
The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.